Friday, October 13, 2017 9:42:21 AM
REUTERS 8:35 AM ET 10/13/2017
Symbol Last Price Change
RVXCF 1.4184up 0 (0%)
QUOTES AS OF 02:52:01 PM ET 10/12/2017
Oct 13 (Reuters) - Resverlogix Corp(RVXCF):
* Resverlogix(RVXCF) announces $87 million private placement with shenzhen hepalink
* Resverlogix Corp(RVXCF) - ?net proceeds of offering will primarily be used to repay company's $68.8 million secured loan which matures on December 26, 2017?
* Resverlogix Corp(RVXCF) - ? private placement of 60.4 million equity units to Shenzhen Hepalink Pharmaceutical Co. Ltd. At a price of $1.44 per unit?
* Resverlogix-Proceeds will also be used to fund research,development activities for clinical trial activities related to phase 3 betonmace trial?
* Resverlogix(RVXCF) - ? placement to address co's financial difficulties by providing sufficient funds to repay loan and to satisfy short term cash requirements? Source text for Eikon: Further company coverage:
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM